Multiple Variants Of Meningococcal Protein Nmb1870

Patent No. EP2258716 (titled "Multiple Variants Of Meningococcal Protein Nmb1870") was filed by GlaxoSmithKline Biologicals SA on Nov 21, 2003. The application was issued on Jul 16, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERApr 16, 2015PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2258716

GLAXOSMITHKLINE BIOLOGICALS SA
Application Number
EP10178923A
Filing Date
Nov 21, 2003
Status
Revoked
Publication Date
Jul 16, 2014